Page last updated: 2024-11-01

nisoldipine and Genetic Diseases

nisoldipine has been researched along with Genetic Diseases in 1 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Splawski, I1
Timothy, KW1
Sharpe, LM1
Decher, N1
Kumar, P1
Bloise, R1
Napolitano, C1
Schwartz, PJ1
Joseph, RM1
Condouris, K1
Tager-Flusberg, H1
Priori, SG1
Sanguinetti, MC1
Keating, MT1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives[NCT04832126]100 participants (Anticipated)Observational2018-01-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for nisoldipine and Genetic Diseases

ArticleYear
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
    Cell, 2004, Oct-01, Volume: 119, Issue:1

    Topics: Abnormalities, Multiple; Action Potentials; Animals; Arrhythmias, Cardiac; Autistic Disorder; Brain;

2004